Format

Send to

Choose Destination
Diabetologia. 2019 Oct 14. doi: 10.1007/s00125-019-04994-8. [Epub ahead of print]

Proinsulin peptide promotes autoimmune diabetes in a novel HLA-DR3-DQ2-transgenic murine model of spontaneous disease.

Author information

1
School of Immunology and Microbial Sciences, Faculty of Life Sciences & Medicine, King's College London, 2nd Floor Borough Wing, Guy's Hospital, Great Maze Pond, London, SE1 9RT, UK.
2
UCB Pharma Ltd, Slough, UK.
3
Department of Metabolism, Digestion and Reproduction, Chelsea & Westminster Hospital, London, UK.
4
School of Immunology and Microbial Sciences, Faculty of Life Sciences & Medicine, King's College London, 2nd Floor Borough Wing, Guy's Hospital, Great Maze Pond, London, SE1 9RT, UK. mark.peakman@kcl.ac.uk.
5
Institute of Diabetes, Endocrinology and Obesity, King's Health Partners, London, UK. mark.peakman@kcl.ac.uk.

Abstract

AIMS/HYPOTHESIS:

The molecular basis for the pathological impact of specific HLA molecules on autoimmune diseases such as type 1 diabetes remains unclear. Recent natural history studies in children have indicated a link between specific HLA genotypes and the first antigenic target against which immune responses develop. We set out to examine this link in vivo by exploring the diabetogenicity of islet antigens on the background of a common diabetes-associated HLA haplotype.

METHODS:

We generated a novel HLA-transgenic mouse model that expresses high-risk genes for type 1 diabetes (DRB1*03:01-DQA1*05:01-DQB1*02:01) as well as human CD80 under the rat insulin promoter and human CD4, on a C57BL/6 background. Adjuvanted antigen priming was used to reveal the diabetogenicity of candidate antigens and peptides.

RESULTS:

HLA-DR3-DQ2+huCD4+IA/IE-/-RIP.B7.1+ mice spontaneously developed autoimmune diabetes (incidence 46% by 35 weeks of age), accompanied by numerous hallmarks of human type 1 diabetes (autoantibodies against GAD65 and proinsulin; pancreatic islet infiltration by CD4+, CD8+ B220+, CD11b+ and CD11c+ immune cells). Disease was markedly accelerated and had deeper penetrance after adjuvanted antigen priming with proinsulin (mean onset 11 weeks and incidence 100% by 20 weeks post challenge). Moreover, the diabetogenic effect of proinsulin located to the 15-residue B29-C11 region.

CONCLUSIONS/INTERPRETATION:

Our study identifies a proinsulin-derived peptide region that is highly diabetogenic on the HLA-DR3-DQ2 background using an in vivo model. This approach and the peptide region identified may have wider implications for future studies of human type 1 diabetes.

KEYWORDS:

HLA-DQ2; HLA-DR3; Mouse model; Proinsulin; Type 1 diabetes

PMID:
31612266
DOI:
10.1007/s00125-019-04994-8

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center